Annual Net Income
$2.51 M
-$3.77 M-60.02%
31 December 2023
Summary:
Vanda Pharmaceuticals annual net profit is currently $2.51 million, with the most recent change of -$3.77 million (-60.02%) on 31 December 2023. During the last 3 years, it has fallen by -$20.83 million (-89.25%). VNDA annual net income is now -97.83% below its all-time high of $115.55 million, reached on 31 December 2019.VNDA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$5.32 M
-$806.00 K-17.84%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly net profit is currently -$5.32 million, with the most recent change of -$806.00 thousand (-17.84%) on 30 September 2024. Over the past year, it has dropped by -$5.46 million (-3986.13%). VNDA quarterly net income is now -105.30% below its all-time high of $100.42 million, reached on 30 September 2019.VNDA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$16.39 M
-$5.46 M-49.98%
30 September 2024
Summary:
Vanda Pharmaceuticals TTM net profit is currently -$16.39 million, with the most recent change of -$5.46 million (-49.98%) on 30 September 2024. Over the past year, it has dropped by -$28.16 million (-239.24%). VNDA TTM net income is now -113.47% below its all-time high of $121.70 million, reached on 30 September 2019.VNDA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.0% | -3986.1% | -239.2% |
| 3 y3 years | -89.3% | -168.5% | -147.8% |
| 5 y5 years | -90.0% | -105.3% | -113.5% |
VNDA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.4% | at low | -168.5% | +17.2% | -147.8% | at low |
| 5 y | 5 years | -97.8% | at low | -105.3% | +17.2% | -113.5% | at low |
| alltime | all time | -97.8% | +103.4% | -105.3% | +79.9% | -113.5% | +79.0% |
Vanda Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.32 M(+17.8%) | -$16.39 M(+50.0%) |
| June 2024 | - | -$4.52 M(+9.0%) | -$10.93 M(+123.5%) |
| Mar 2024 | - | -$4.15 M(+72.8%) | -$4.89 M(-294.9%) |
| Dec 2023 | $2.51 M(-60.0%) | -$2.40 M(-1851.8%) | $2.51 M(-78.7%) |
| Sept 2023 | - | $137.00 K(-91.0%) | $11.77 M(-21.0%) |
| June 2023 | - | $1.52 M(-53.3%) | $14.90 M(-6.6%) |
| Mar 2023 | - | $3.25 M(-52.6%) | $15.96 M(+154.3%) |
| Dec 2022 | $6.28 M(-81.1%) | $6.86 M(+109.8%) | $6.28 M(-3.3%) |
| Sept 2022 | - | $3.27 M(+27.0%) | $6.49 M(-40.9%) |
| June 2022 | - | $2.57 M(-140.0%) | $10.99 M(-39.2%) |
| Mar 2022 | - | -$6.43 M(-190.8%) | $18.07 M(-45.5%) |
| Dec 2021 | $33.15 M(+42.1%) | $7.08 M(-8.9%) | $33.15 M(-3.2%) |
| Sept 2021 | - | $7.77 M(-19.5%) | $34.26 M(+5.6%) |
| June 2021 | - | $9.65 M(+11.6%) | $32.44 M(+3.0%) |
| Mar 2021 | - | $8.65 M(+5.6%) | $31.50 M(+35.0%) |
| Dec 2020 | $23.34 M(-79.8%) | $8.19 M(+37.7%) | $23.34 M(+20.5%) |
| Sept 2020 | - | $5.95 M(-31.8%) | $19.36 M(-83.0%) |
| June 2020 | - | $8.71 M(+1693.0%) | $113.84 M(-2.4%) |
| Mar 2020 | - | $486.00 K(-88.5%) | $116.65 M(+1.0%) |
| Dec 2019 | $115.55 M(+358.4%) | $4.22 M(-95.8%) | $115.55 M(-5.0%) |
| Sept 2019 | - | $100.42 M(+771.3%) | $121.70 M(+327.8%) |
| June 2019 | - | $11.53 M(-1983.3%) | $28.45 M(+32.1%) |
| Mar 2019 | - | -$612.00 K(-105.9%) | $21.53 M(-14.6%) |
| Dec 2018 | $25.21 M(-261.9%) | $10.36 M(+44.5%) | $25.21 M(+93.8%) |
| Sept 2018 | - | $7.17 M(+55.5%) | $13.01 M(+909.3%) |
| June 2018 | - | $4.61 M(+50.4%) | $1.29 M(-126.5%) |
| Mar 2018 | - | $3.07 M(-266.8%) | -$4.86 M(-68.8%) |
| Dec 2017 | -$15.57 M(-13.6%) | -$1.84 M(-59.6%) | -$15.57 M(+8.6%) |
| Sept 2017 | - | -$4.55 M(+196.6%) | -$14.33 M(+40.3%) |
| June 2017 | - | -$1.53 M(-79.9%) | -$10.21 M(-23.2%) |
| Mar 2017 | - | -$7.64 M(+1165.7%) | -$13.30 M(-26.2%) |
| Dec 2016 | -$18.01 M(-54.8%) | -$604.00 K(+40.5%) | -$18.01 M(-44.1%) |
| Sept 2016 | - | -$430.00 K(-90.7%) | -$32.20 M(-21.9%) |
| June 2016 | - | -$4.62 M(-62.6%) | -$41.23 M(-1.8%) |
| Mar 2016 | - | -$12.36 M(-16.5%) | -$42.00 M(+5.4%) |
| Dec 2015 | -$39.87 M(-297.5%) | -$14.80 M(+56.4%) | -$39.87 M(-189.3%) |
| Sept 2015 | - | -$9.46 M(+75.7%) | $44.65 M(-15.3%) |
| June 2015 | - | -$5.39 M(-47.3%) | $52.69 M(+44.4%) |
| Mar 2015 | - | -$10.22 M(-114.7%) | $36.50 M(+80.8%) |
| Dec 2014 | $20.19 M | $69.72 M(-4989.1%) | $20.18 M(-135.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$1.43 M(-93.4%) | -$57.28 M(-6.5%) |
| June 2014 | - | -$21.57 M(-18.7%) | -$61.26 M(+42.2%) |
| Mar 2014 | - | -$26.53 M(+242.5%) | -$43.07 M(+104.6%) |
| Dec 2013 | -$21.05 M(-26.4%) | -$7.75 M(+43.3%) | -$21.05 M(+2.1%) |
| Sept 2013 | - | -$5.41 M(+59.8%) | -$20.63 M(+0.4%) |
| June 2013 | - | -$3.38 M(-25.1%) | -$20.55 M(-18.4%) |
| Mar 2013 | - | -$4.52 M(-38.3%) | -$25.17 M(-12.0%) |
| Dec 2012 | -$28.62 M(+192.0%) | -$7.32 M(+37.5%) | -$28.62 M(+6.7%) |
| Sept 2012 | - | -$5.33 M(-33.5%) | -$26.82 M(+9.2%) |
| June 2012 | - | -$8.01 M(+0.6%) | -$24.57 M(+37.2%) |
| Mar 2012 | - | -$7.96 M(+44.2%) | -$17.90 M(+82.6%) |
| Dec 2011 | -$9.80 M(-236.3%) | -$5.52 M(+79.7%) | -$9.80 M(+371.3%) |
| Sept 2011 | - | -$3.07 M(+129.2%) | -$2.08 M(-149.8%) |
| June 2011 | - | -$1.34 M(-1086.0%) | $4.18 M(-38.5%) |
| Mar 2011 | - | $136.00 K(-93.8%) | $6.80 M(-5.5%) |
| Dec 2010 | $7.19 M(-120.1%) | $2.20 M(-30.9%) | $7.19 M(-269.4%) |
| Sept 2010 | - | $3.18 M(+148.8%) | -$4.24 M(-72.0%) |
| June 2010 | - | $1.28 M(+142.0%) | -$15.15 M(-47.4%) |
| Mar 2010 | - | $529.00 K(-105.7%) | -$28.83 M(-19.6%) |
| Dec 2009 | -$35.86 M(-29.8%) | -$9.24 M(+19.6%) | -$35.86 M(+5.1%) |
| Sept 2009 | - | -$7.73 M(-37.7%) | -$34.13 M(-8.4%) |
| June 2009 | - | -$12.39 M(+90.5%) | -$37.27 M(-2.9%) |
| Mar 2009 | - | -$6.50 M(-13.3%) | -$38.37 M(-24.9%) |
| Dec 2008 | -$51.06 M(-31.1%) | -$7.50 M(-31.0%) | -$51.06 M(-20.6%) |
| Sept 2008 | - | -$10.87 M(-19.5%) | -$64.31 M(-14.7%) |
| June 2008 | - | -$13.49 M(-29.7%) | -$75.38 M(-3.2%) |
| Mar 2008 | - | -$19.20 M(-7.5%) | -$77.87 M(+5.1%) |
| Dec 2007 | -$74.07 M(+16.6%) | -$20.75 M(-5.4%) | -$74.07 M(+13.6%) |
| Sept 2007 | - | -$21.94 M(+37.3%) | -$65.21 M(+17.7%) |
| June 2007 | - | -$15.98 M(+3.8%) | -$55.39 M(-8.9%) |
| Mar 2007 | - | -$15.39 M(+29.4%) | -$60.78 M(-4.3%) |
| Dec 2006 | -$63.51 M(+165.9%) | -$11.89 M(-1.9%) | -$63.51 M(+8.6%) |
| Sept 2006 | - | -$12.12 M(-43.3%) | -$58.46 M(+12.3%) |
| June 2006 | - | -$21.37 M(+17.9%) | -$52.04 M(+44.0%) |
| Mar 2006 | - | -$18.12 M(+164.8%) | -$36.14 M(+51.3%) |
| Dec 2005 | -$23.88 M(+152.1%) | -$6.84 M(+20.0%) | -$23.88 M(+40.2%) |
| Sept 2005 | - | -$5.70 M(+4.3%) | -$17.04 M(+50.3%) |
| June 2005 | - | -$5.47 M(-6.8%) | -$11.34 M(+93.2%) |
| Mar 2005 | - | -$5.87 M | -$5.87 M |
| Dec 2004 | -$9.47 M | - | - |
FAQ
- What is Vanda Pharmaceuticals annual net profit?
- What is the all time high annual net income for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual net income year-on-year change?
- What is Vanda Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly net income year-on-year change?
- What is Vanda Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals TTM net income year-on-year change?
What is Vanda Pharmaceuticals annual net profit?
The current annual net income of VNDA is $2.51 M
What is the all time high annual net income for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual net profit is $115.55 M
What is Vanda Pharmaceuticals annual net income year-on-year change?
Over the past year, VNDA annual net profit has changed by -$3.77 M (-60.02%)
What is Vanda Pharmaceuticals quarterly net profit?
The current quarterly net income of VNDA is -$5.32 M
What is the all time high quarterly net income for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly net profit is $100.42 M
What is Vanda Pharmaceuticals quarterly net income year-on-year change?
Over the past year, VNDA quarterly net profit has changed by -$5.46 M (-3986.13%)
What is Vanda Pharmaceuticals TTM net profit?
The current TTM net income of VNDA is -$16.39 M
What is the all time high TTM net income for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high TTM net profit is $121.70 M
What is Vanda Pharmaceuticals TTM net income year-on-year change?
Over the past year, VNDA TTM net profit has changed by -$28.16 M (-239.24%)